CEO David Ricks got a 10% raise in 2024, as a surge in demand for weigh-loss drugs has propelled the pharma giant into the ...

Presiding over the upward trajectory of Eli Lilly over the last eight years is paying off nicely for CEO David Ricks. | ...

制药巨头礼来周三宣布，计划投资至少270亿美元在美国建设四个新的生产基地，以满足其畅销减肥药和糖尿病药物的旺盛需求，并支持其他疾病的新药研发。 礼来CEO David ...

在美国制药行业迈向新时代之际，制药巨头礼来公司近日宣布一项前所未有的投资计划，计划在美国新建四座药物生产设施，投资高达270亿美元！这是近年来美国制药领域最大规模的扩张举动，旨在进一步强化供应链的自主性并积极应对仿制药市场的冲击。

Eli Lilly Chief Executive David Ricks annual compensation rose to $29.2 million in 2024, a 10% increase from the $26.2 million he received a year earlier.

特朗普周四在白宫会见了包括礼来首席执行官 David Ricks、默克首席执行官 Robert Davis、辉瑞首席执行官 Albert Bourla 和业内最大游说组织负责人 Stephen Ubl 在内的制药公司高管。

While announcing billions of dollars in new U.S. investments, David Ricks called for an extension of 2017 tax cuts and ...

Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...

CNBC Eli Lilly CEO David Ricks: Projecting 32% total growth for company in 2025 Posted: January 14, 2025 | Last updated: January 15, 2025 Eli Lilly CEO David Ricks joins 'Squawk on the Street' to ...

David Ricks, the CEO of Mounjaro and Zepbound maker Eli Lilly, explained why these medications are so expensive on the "In Good Company with Nicolai Tangen" podcast this week. 1. Time and money ...

The UK has become a “relatively small market” since leaving the European Union and must develop a different investment proposition from its counterparts in order to be interesting to ...